The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this technique offers a simpler way to provide GLP-1 https://elainevsrc416520.newbigblog.com/47843022/glp-1-patches-a-novel-approach-to-blood-sugar-control